prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, Surgical Pathology:Finels. CLINICAL HISTORY: Large carcinoma in right breast. GROSS EXAMINATION: A. "Right breast and axilla tissue", in formalin. Received is a 30 x 18 x 4 cm. mastectomy specimen with a 14 x 7.5 x 1.0 cm attached axillary tail. There is. a. 21 x 15 cm skin ellipse. Sectioning the specimen reveals a 5 x 4.5 x 4 cm. mass in the mid upper outer quadrant consisting of firm, white, hemorrhagic. tissue. The mass is 2 cm from the deep surgical margin and 1 cm from the skin. ellipse. The remaining breast tissue appears unremarkable. The deep surgical. margin is inked blue. The axillary tail was sectioned into the proximal,. middle, and distal portion and lymph node candidates were identified. BLOCK SUMMARY: A1- section of nipple. A2- tumor in surgical margin. A3- tumor and skin margin. A4- tumor. A5- upper outer quadrant. A6- upper inner quadrant. A7- lower outer quadrant. A8- lower inner quadrant. A9- proximal region three lymph node candidates. A10- mid region two lymph node candidates. A11- mid region two lymph node candidates. A12- mid region two lymph node candidates. A13- distal region viable candidates. A14- distal region four lymph node candidates. A15- distal region four lymph node candidates. A16- distal region five lymph node candidates. A17- distal region one lymph node candidate. Dr. DIAGNOSIS: A. "RIGHT BREAST AND AXILLA TISSUE", (MASTECTOMY, AXILLARY DISSECTION) : INVASIVE DUCTAL CARCINOMA, NSABP HISTOLOGIC GRADE III, CYTOLOGIC GRADE III. TUMOR MEASURES 5 CM IN ITS GREATEST DIMENSION. TUMOR EXTENDS TO WITHIN 2 CM OF THE DEEP SURGICAL MARGIN. 27 LYMPH NODES, ALL NEGATIVE FOR MALIGNANCY. BENIGN PROLIFERATIVE CHANGES INCLUDE BLUNT DUCT ADENOSIS, INTRADUCTAL. HYPERPLASIA, AND FIBROSIS. OPERATIVE MARGINS FREE OF MALIGNANCY IN SECTIONS OBTAINED. COMMENT: No identifiable intraductal carcinoma is seen. Dati. eBrowser Result for. 1 of 1.

expanded version (tokens=886) : 
 The breast pathology report reveals that the patient has invasive ductal carcinoma. The subtype of the cancer is basal and it is NSABP histologic grade III and cytologic grade III. The tumor measures 5 cm in its greatest dimension and extends to within 2 cm of the deep surgical margin. The report also mentions that there are no identifiable intraductal carcinoma cells.

The surgical margin and all 27 lymph nodes tested for malignancy were negative for any cancerous cells. The benign proliferative changes observed include blunt duct adenosis, intraductal hyperplasia, and fibrosis.

There is no mention of necrosis or tumor-infiltrating lymphocytes in the report. Calcifications and receptor status are also not mentioned in the report. However, further ancillary testing such as IHC may have been conducted, but there is no mention of it in the report.

In summary, the breast pathology report indicates a basal subtype invasive ductal carcinoma with NSABP histologic grade III and cytologic grade III. The report also states that the surgical margins are clear and that no malignancy was found in the lymph nodes.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1019) : 
 The patient has been diagnosed with invasive ductal carcinoma, with a basal subtype and histologic grade III. The tumor measures 5 cm. Surgical margins are clear and lymph nodes are negative for malignancy. There is no mention of necrosis or tumor-infiltrating lymphocytes, receptor status or calcification. Ancillary testing such as IHC may have been conducted, but there is no mention of it in the report.

